Analyzing the price chart for Cell Therapeutics (NASDAQ:CTIC) has revealed a potential bearish inside day candle pattern. Yesterday's price range of $1.36 and $1.42 is within the prior day's high and low of the day. This trading action often signifies indecision by bulls and bears to drive prices higher or lower and often implies a possible change in trend. Owners of Cell Therapeutics may want to consider a possible hedge in the event a pullback occurs. Look for confirmation in the next few trading days.
Potential upside of 42.9% exists for Cell Therapeutics, based on a current level of $1.40 and analysts' average consensus price target of $2.00. The stock should find initial support at its 50-day moving average (MA) of $1.13 and further support at its 200-day MA of $1.05.
Cell Therapeutics, Inc. is a biopharmaceutical company. The Company researches and develops cancer drugs.
In the past 52 weeks, shares of Cell Therapeutics have traded between a low of $0.21 and a high of $2.16 and closed yesterday at $1.40, which is 567% above that low price. Over the past week, the 200-day moving average (MA) has gone up 1.7% while the 50-day MA has advanced 1.3%.
